Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. 2013

Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Disease, Xijing Hospital, Fourth Military Medical University, 127 Changle Western Road, Xi'an 710032, Shaanxi Province, China.

BACKGROUND Accumulating evidences have identified the immunoregulatory features of stem cells. In this study, the immunoregulation of bone marrow-derived stem cells (BMSCs) transplanted into patients with HBV-related decompensated cirrhosis and mouse model of liver injury induced by carbon tetrachloride (CCl4) administration was observed. RESULTS Compared with healthy controls, patients with HBV-related decompensated cirrhosis showed significantly higher levels of TNF-alpha, IL-12, TGF-beta1, IL-17, and IL-8. However, only IL-17 was markedly decreased after autologous BMSCs transplantation during their follow-up. The same results were found in the CCl4-treated mice. Furthermore, we found that exogenous IL-17 partly abolished the therapeutic effect of BMSCs whereas IL-17-specific antibody promoted improvement of liver injury in CCl4-treated mice, resembling the therapeutic effect of BMSCs transplantation. CONCLUSIONS These data suggested that BMSCs transplantation induces a decrease of IL-17 level, which at least in part delineates the mechanisms of stem cells-mediated therapeutic benefit on liver disease.

UI MeSH Term Description Entries

Related Publications

Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
June 2015, Clinical and molecular hepatology,
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
April 2011, PloS one,
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
November 2012, Hepatology (Baltimore, Md.),
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
December 2019, Cellular oncology (Dordrecht),
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
February 2018, Biochemical and biophysical research communications,
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
February 2018, Cytotherapy,
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
October 2021, Cellular oncology (Dordrecht),
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
September 2019, Molecular and cellular biochemistry,
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
July 2008, Stem cells (Dayton, Ohio),
Linhua Zheng, and Jindong Chu, and Yongquan Shi, and Xinmin Zhou, and Ling Tan, and Qiang Li, and Lina Cui, and Zheyi Han, and Ying Han, and Daiming Fan
February 2017, Clinical and investigative medicine. Medecine clinique et experimentale,
Copied contents to your clipboard!